GENOCEA BIOSCIENCES, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Grant revenue
License revenue
Operating expenses:
Research and development
General and administrative
Restructuring costs
Refund of research and development expense
Total operating expenses

Loss from operations
Other income (expense):
Interest income
Change in fair value of warrants
Interest expense, net
Other expense
Total other income

Net loss
Unrealized loss on available-for-sale securities
Comprehensive loss
Net loss per share - basic and diluted (in USD per share)
Weighted-average number of common shares used in computing net loss per share (in shares)
Net loss per share:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average number of shares used in computing net loss per share:
Weighted-average common stock outstanding - basic
Weighted-average common stock outstanding - diluted

Comments